Two firms raised price targets on ORCL on Monday. Evercore ISI lifted its target to $245 from $220. Oppenheimer went further, raising to $275 from $235. Both firms kept Buy ratings. The $614 billion tech giant is drawing strong bullish calls heading into the second half.
ADBE moved the other way. Stifel cut its target to $350 from $400, though it kept a Buy rating. Adobe's $101 billion market cap and 4.8% short interest suggest the market remains divided on its AI monetisation path.
Health insurers also caught upgrades. Mizuho raised HUM to a Buy with a $390 target, up from $335. That is a $55 jump. Humana has a 5% short interest, meaning some bears could be squeezed if the upgrade sparks momentum. The same analyst lifted UNH to $460 from $440.
Evercore ISI also raised targets on asset managers. TROW moved to $111 from $106. IVZ got a nudge to $31 from $28. Both kept Hold ratings. The firm appears to be marking up the sector broadly after recent price gains.
CIEN saw its consensus target edge down to $560 from $565, a minor but notable reversal for a stock that had been a market favourite.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
